Antoni P.A. Hendrickx (@aphendrickx.bsky.social)

New work of Max Allewijn and colleagues is published! 💡we performed comparative genomics on carbapenem-resistant Acinetobacter baumannii (CRAb) in the Netherlands journals.asm.org/doi/10.1128/... #RIVM #surveillance #CRAB

loading . . .

Comparative genomic surveillance of carbapenem-resistant Acinetobacter baumannii in the Netherlands in 2015–2017 and 2022–2024 | Microbiology Spectrum In 2015–2017 and 2022–2024, pilot surveillance of carbapenem-resistant Acinetobacter baumannii (CRAb) was performed in the Netherlands. Three distinct groups were compared based on epidemiological and genomic data: CRAb from 2015 to 2017 and for the 2022–2024 period, CRAb in patients from the Netherlands, and CRAb in patients from Ukraine in the Netherlands. The genomic epidemiology of CRAb has been mostly stable between 2015–2017 and 2022–2024 but seems to be strongly affected by the introduction of CRAb from foreign countries. A proportion of the 2022–2024 isolates were from Ukrainian patients. The resistance genes of CRAb from Ukrainian patients were different from those of the Netherlands. CRAb in the Netherlands are acquiring New Delhi metallo-β-lactamase-carbapenemase genes, aided by the introduction of CRAb from foreign countries. Healthcare professionals should remain aware of the risk of hospitalization in a high-risk country and the potential secondary transmission of CRAb to patients in countries with a low prevalence of this organism. https://journals.asm.org/doi/10.1128/spectrum.02602-25